Investigating neoplastic progression of ulcerative colitis with label-free comparative proteomics

Journal of Proteome Research

Volumn 10, Issue 1, 2011, Pages 200-209

  May, Damon ^a,b   Pan, Sheng ^a,c   Crispin, David A ^c   Lai, Keith ^b   Bronner, Mary P ^b   Hogan, Jason ^b   Hockenbery, David M ^b   McIntosh, Martin ^b   Brentnall, Teresa A ^c   Chen, Ru ^c  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

AMT; Biomarker; Colorectal cancer; Dysplasia; Label free; Mass spectrometry; Proteomics; Ulcerative colitis

Indexed keywords

BIOLOGICAL MARKER; CARBAMOYL PHOSPHATE SYNTHASE; CELL PROTEIN; CYTOSKELETON PROTEIN; MITOCHONDRIAL PROTEIN; PROTEIN; RAS PROTEIN; REGULATOR PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1;

APOPTOSIS; ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE COURSE; DYSPLASIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALIGNANT TRANSFORMATION; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; RECTUM MUCOSA; SENSITIVITY AND SPECIFICITY; ULCERATIVE COLITIS;

COLITIS, ULCERATIVE; COLON; DISEASE PROGRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASTIC PROCESSES; PROTEINS; PROTEOMICS; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL;

EID: 79951536087     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr100574p     Document Type: Article

References (31)

1. Ekbom, A.; Helmick, C.; Zack, M.; Adami, H. O. Ulcerative colitis and colorectal cancer. A population-based study. N. Engl. J. Med. 1990, 323 (18), 1228-33. (Pubitemid 20366527)
2. Prior, P.; Gyde, S. N.; Macartney, J. C.; Thompson, H.; Waterhouse, J. A.; Allan, R. N. Cancer morbidity in ulcerative colitis. Gut 1982, 23 (6), 490-7. (Pubitemid 12119347)
3. Rubin, C. E.; Haggitt, R. C.; Burmer, G. C.; Brentnall, T. A.; Stevens, A. C.; Levine, D. S.; Dean, P. J.; Kimmey, M.; Perera, D. R.; Rabinovitch, P. S. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology 1992, 103 (5), 1611-20.
4. Riddell, R. H.; Goldman, H.; Ransohoff, D. F.; Appelman, H. D.; Fenoglio, C. M.; Haggitt, R. C.; Ahren, C.; Correa, P.; Hamilton, S. R.; Morson, B. C. et al., Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum. Pathol. 1983, 14 (11), 931-68.
5. America, A. H.; Cordewener, J. H.; Comparative, L. C.-M. S. a landscape of peaks and valleys. Proteomics 2008, 8 (4), 731-49.
6. Mueller, L. N.; Brusniak, M. Y.; Mani, D. R.; Aebersold, R. An assessment of software solutions for the analysis of mass spectrometry based quantitative proteomics data. J. Proteome Res. 2008, 7 (1), 51-61. (Pubitemid 351171115)
7. Choi, H.; Fermin, D.; Nesvizhskii, A. Significance Analysis of Spectral Count Data in Label-free Shotgun Proteomics. Mol. Cell. Proteomics 2008, 7 (12), 2373-85.
8. Ryu, S.; Gallis, B.; Goo, Y.; Shaffer, S. A.; Radulovic, D.; Goodlett, D. Comparison of a Label-Free Quantitative Proteomic Method Based on Peptide Ion Current Area to the Isotope Coded Affinity Tag Method. Cancer Inform. 2008, 6, 243-255.
9. Old, W.; Meyer-Arendt, K.; Aveline-Wolf, L.; Pierce, K.; Mendoza, A.; Sevinsky, J.; Resing, K.; Ahn, N. Comparison of Label-free Methods for Quantifying Human Proteins by Shotgun Proteomics. Mol. Cell. Proteomics 2005, 4, 1487-1502. (Pubitemid 41555475)
10. Brentnall, T. A.; Pan, S.; Bronner, M. P.; Crispin, D. A.; Mirzaei, H.; Cooke, K.; Tamura, Y.; Nikolskaya, T.; Jebailey, L.; Goodlett, D. R.; McIntosh, M.; Aebersold, R.; Rabinovitch, P. S.; Chen, R. Proteins That Underlie Neoplastic Progression of Ulcerative Colitis. Proteomics Clin. Appl. 2009, 3 (11), 1326-1337.
11. Rabinovitch, P. S.; Dziadon, S.; Brentnall, T. A.; Emond, M. J.; Crispin, D. A.; Haggitt, R. C.; Bronner, M. P. Pancolonic chromosomal instability precedes dysplasia and cancer in ulcerative colitis. Cancer Res. 1999, 59 (20), 5148-53. (Pubitemid 29503975)
12. Licklider, L. J.; Thoreen, C. C.; Peng, J.; Gygi, S. P. Automation of nanoscale microcapillary liquid chromatography-tandem mass spectrometry with a vented column. Anal. Chem. 2002, 74, 3076-3083. (Pubitemid 34755220)
13. Craig, R.; Beavis, R. C. TANDEM: matching proteins with tandem mass spectra. Bioinformatics 2004, 20 (9), 1466-7. (Pubitemid 38931421)
14. Keller, A.; Eng, J. K.; Zhang, N.; Li, X. J.; Aebersold, R. A uniform proteomics MS/MS analysis platform utilizing open XML file formats. Mol. Syst. Biol. 2005, 1, 1-8.
15. Keller, A.; Nesvizhskii, A. I.; Kolker, E.; Aebersold, R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 2002, 74 (20), 5383-92. (Pubitemid 35215372)
16. May, D.; Fitzgibbon, M.; Liu, Y.; Holzman, T.; Eng, J.; Kemp, C. J.; Whiteaker, J.; Paulovich, A.; McIntosh, M. A Platform for Accurate Mass and Time Analyses of Mass Spectrometry Data. J. Proteome Res. 2007, 6, 2685-94. (Pubitemid 47122364)
17. Bellew, M.; Coram, M.; Fitzgibbon, M.; Igra, M.; Randolph, T.; Wang, P.; May, D.; Eng, J.; Fang, R.; Lin, C.; Chen, J.; Goodlett, D.; Whiteaker, J.; Paulovich, A.; McIntosh, M. A suite of algorithms for the comprehensive analysis of complex protein mixtures using high-resolution LC-MS. Bioinformatics 2006, 22 (15), 1902-9. (Pubitemid 44283036)
18. May, D.; Liu, Y.; Law, W.; Fitzgibbon, M.; Wang, H.; Hanash, S.; McIntosh, M. Peptide Sequence Confidence in Accurate Mass and Time Analysis and Its Use in Complex Proteomics Experiments. J. Proteome Res. 2008, 7, 5148-56.
19. Wang, P.; Tang, H.; Zhang, H.; Whiteaker, J.; Paulovich, A. G.; McIntosh, M. Normalization regarding non-random missing values in high-throughput mass spectrometry data. Proc. Pac. Symp. Biocomput. 2006, 11, 315-326.
20. Deutsch, E. W.; Mendoza, A.; Shteynberg, D.; Farrah, T.; Lam, H.; Tasman, N.; Sun, Z.; Nilsson, E.; Pratt, B.; Prazen, B.; Eng, J.; Martin, D.; Nesvizhskii, A.; Aebersold, R. A guided tour of the Trans- Proteomic Pipeline. Proteomics 2010, 10, 1-10.
21. Fang, Q.; Strand, A.; Law, W.; Faca, V. M.; Fitzgibbon, M. P.; Hamel, N.; Houle, B.; Liu, X.; May, D. H.; Poschmann, G.; Roy, L.; Stuhler, K.; Ying, W.; Zhang, J.; Zheng, Z.; Bergeron, J. J.; Hanash, S.; He, F.; Leavitt, B. R.; Meyer, H. E.; Qian, X.; McIntosh, M. W. Brainspecific proteins decline in the cerebrospinal fluid of humans with Huntington's disease. Mol. Cell. Proteomics 2008, 8 (3), 451-66.
22. Storey, J. D.; Tibshirani, R. Statistical significance for genomewide studies. Proc. Natl. Acad. Sci. U.S.A. 2003, 100 (16), 9440-5. (Pubitemid 37033947)
23. Patel, V. J.; Thalassinos, K.; Slade, S. E.; Connolly, J. B.; Crombie, A.; Murrell, J. C.; Scrivens, J. H. A comparison of labeling and labelfree mass spectrometry-based proteomics approaches. J. Proteome Res. 2009, 8 (7), 3752-9.
24. Dennis, G., Jr.; Sherman, B. T.; Hosack, D. A.; Yang, J.; Gao, W.; Lane, H. C.; Lempicki, R. A. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 2003, 4 (5), P3.
25. Huang da, W.; Sherman, B. T.; Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4 (1), 44-57.
26. Pawlak, G.; Helfman, D. M. Cytoskeletal changes in cell transformation and tumorigenesis. Curr. Opin. Genet. Dev. 2001, 11 (1), 41-7.
27. Goldfinger, L. E. Choose your own path: specificity in Ras GTPase signaling. Mol. Biosyst. 2008, 4 (4), 293-9. (Pubitemid 351422584)
28. Ghobrial, I. M.; Witzig, T. E.; Adjei, A. A. Targeting apoptosis pathways in cancer therapy. CA Cancer J. Clin. 2005, 55 (3), 178-94. (Pubitemid 40826487)
29. Costantino, E.; Maddalena, F.; Calise, S.; Piscazzi, A.; Tirino, V.; Fersini, A.; Ambrosi, A.; Neri, V.; Esposito, F.; Landriscina, M. TRAP1, a novel mitochondrial chaperone responsible for multidrug resistance and protection from apoptotis in human colorectal carcinoma cells. Cancer Lett. 2009, 279 (1), 39-46.
30. Macleod, K.; Mullen, P.; Sewell, J.; Rabiasz, G.; Lawrie, S.; Miller, E.; Smyth, J. F.; Langdon, S. P. Altered ErbB receptor signaling and gene expression in cisplatin-resistant ovarian cancer. Cancer Res. 2005, 65 (15), 6789-800. (Pubitemid 41060717)
31. Leav, I.; Plescia, J.; Goel, H. L.; Li, J.; Jiang, Z.; Cohen, R. J.; Languino, L. R.; Altieri, D. C. Cytoprotective mitochondrial chaperone TRAP-1 as a novel molecular target in localized and metastatic prostate cancer. Am. J. Pathol. , 176 (1), 393-401.